S Gliptin Plus (50/1000mg) 14 Tablets
Sitagliptin and metformin 50/1000mg for type 2 diabetes.
S Gliptin Plus 50/1000mg combines sitagliptin (a DPP-4 inhibitor) and metformin in a single tablet for type 2 diabetes. Sitagliptin enhances glucose-dependent insulin release; metformin reduces hepatic glucose output and improves insulin sensitivity. Used when dual therapy is needed for glycaemic control.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when dual therapy is appropriate.
Ingredients
Sitagliptin 50mg and metformin hydrochloride 1000mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Risk of lactic acidosis with metformin. Not for type 1 diabetes.
Side Effects
Nausea, diarrhoea, abdominal discomfort, hypoglycaemia when combined with insulin or sulphonylurea. Rare: pancreatitis. Report severe abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Barrett |
| Status | Active |
Related Products
